The Fair Care Act of 2026 fundamentally restructures U.S. healthcare by transforming Health Savings Accounts into the primary savings vehicle, reforming private insurance markets, increasing price transparency, and overhauling Medicare and Medicaid payment structures.
Bruce Westerman
Representative
AR-4
The **Fair Care Act of 2026** is a sweeping overhaul of the U.S. healthcare system focused on shifting benefits toward Health Savings Accounts (HSAs), reforming private insurance markets, and increasing system transparency. Title I centralizes health coverage around HSAs by expanding eligibility and changing contribution rules, while Title II introduces private insurance reforms contingent on the Supreme Court striking down the ACA. The bill also aims to lower costs through increased competition, price transparency, and drug pricing reforms across the entire system, including targeted changes to Medicare and Medicaid.
The Fair Care Act of 2026 aims to fundamentally shift the American healthcare landscape by moving away from traditional employer-sponsored insurance and toward a system built on Health Savings Accounts (HSAs) and increased market competition. The bill expands HSA eligibility to virtually any health plan, including Medicare and Medicaid, and sets new annual contribution limits ranging from $3,600 to $5,000 based on how much the plan covers. It also introduces 'copper' plans on the insurance exchanges—lower-premium options that cover only about 50% of average healthcare costs—while allowing insurers to charge older adults up to five times more than younger ones, a jump from the current three-to-one limit.
This bill effectively bets the farm on HSAs. For the office worker or trade professional, this means more control over your health dollars, but it also comes with a major catch: the bill repeals the employer mandate. Starting in 2027, your boss isn't required to offer insurance at all. Instead, the bill pushes a 'defined-contribution' model where employers might just drop money into your HSA for you to go buy your own plan on an exchange. If you’re a federal employee or work for a company started after 2026, this isn't a choice; the bill mandates this HSA-focused transition. Plus, if you have a 'Cadillac' plan with high-end benefits, anything over $10,200 for individuals (or $27,500 for families) will now count as taxable income, potentially bumping you into a higher tax bracket.
To tackle the rising cost of medicine, the bill aims to get cheaper drugs into your cabinet faster. It slashes the exclusivity period for brand-name biologic drugs from 12 years down to 5, meaning generic-style 'biosimilars' can hit the market much sooner. It also targets the 'middlemen' of the drug world—Pharmacy Benefit Managers (PBMs). Under Title III, PBMs would be forced to pass 100% of the rebates and discounts they negotiate with drug makers directly to you at the pharmacy counter. For a family managing chronic conditions like asthma or diabetes, this could mean immediate, noticeable savings when you swipe your card at the register.
For those on Medicare or Medicaid, the rules are changing. The bill introduces a competitive bidding system for Medicare, where you’ll use an online platform to choose between traditional Medicare and private plans, keeping the savings if you pick a cheaper option. However, it’s not all perks; by 2032, high earners with over $10 million in lifetime wages will be barred from enrolling in Medicare Parts B or D. On the Medicaid side, the bill shifts to a 'per-person' capped payment model for states that opt in. While this aims to control federal spending, it could lead to stricter eligibility checks every six months and restricted federal funding for anyone earning above the poverty line, potentially leaving lower-income workers in a lurch if their state doesn't foot the rest of the bill.
One of the biggest 'what-ifs' involves pre-existing conditions. The bill guarantees coverage regardless of health history, but only if the Supreme Court strikes down the Affordable Care Act—otherwise, the current rules stay in place, creating a period of legal limbo. Additionally, if you’re ever the victim of medical malpractice, your ability to sue for 'pain and suffering' (non-economic damages) would be capped at $250,000. While this is intended to lower the 'defensive medicine' costs that doctors pass on to patients, it significantly limits the payout for someone facing a life-altering injury due to medical error.